CA Stock MarketDetailed Quotes

Doseology Sciences Inc (MOOD)

Watchlist
  • 0.400
  • -0.025-5.88%
15min DelayMarket Closed May 15 15:59 ET
3.20MMarket Cap-2.86P/E (TTM)

Doseology Sciences Inc (MOOD) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Dec 31, 2025
(Q1)Sep 30, 2025
(FY)Jun 30, 2025
(Q4)Jun 30, 2025
(Q3)Mar 31, 2025
(Q2)Dec 31, 2024
(Q1)Sep 30, 2024
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-1,049.38%-680.97K
-51.41%-105.7K
-45.56%-342.24K
-546.87%-101.79K
-279.93%-111.39K
54.83%-59.25K
-18.54%-69.81K
51.12%-235.12K
88.02%-15.74K
69.45%-29.32K
Net income from continuing operations
-480.93%-339.32K
-137.86%-171.91K
-31.76%-447.79K
-118.74%-239.7K
-90.96%-77.41K
47.68%-58.41K
7.44%-72.27K
80.92%-339.85K
90.45%-109.58K
63.34%-40.54K
Operating gains losses
----
----
----
----
----
----
----
-98.36%4.14K
----
----
Depreciation and amortization
----
----
--0
--0
--0
--0
--0
-69.18%20.37K
104.37%797
-97.15%797
Asset impairment expenditure
----
----
----
----
----
----
----
--0
----
----
Remuneration paid in stock
---30.51K
345.99%60.49K
451.65%97.54K
265.15%83.97K
--0
--0
26.05%13.56K
-78.80%17.68K
-184.70%-50.85K
--7.44K
Other non cashItems
----
----
-44.28%16.5K
--0
----
----
----
-96.05%29.62K
-93.03%48.39K
--0
Change In working capital
-37,029.71%-311.15K
151.53%5.72K
-125.78%-8.49K
-40.97%53.93K
-1,794.09%-50.48K
98.38%-838
-16.31%-11.1K
-75.89%32.92K
356.55%91.37K
108.08%2.98K
-Change in receivables
-2,722.75%-38.59K
249.16%10.94K
-362.80%-38.88K
-210.44%-12.28K
-42.37%-17.9K
-105.38%-1.37K
19.74%-7.34K
-78.34%14.8K
294.35%11.12K
-241.31%-12.57K
-Change in inventory
-1,735.25%-33.03K
--0
172.85%22.67K
--0
-24.84%13.36K
104.45%2.02K
13.12%7.29K
-1,826.64%-31.11K
-15.52%-9.92K
582.64%17.78K
-Change in prepaid assets
-7,225.00%-213.75K
-111.29%-18.15K
-124.79%-3.89K
-81.24%2.01K
-7,450.00%-302
-81.30%3K
22.43%-8.59K
-89.04%15.67K
152.78%10.7K
-100.01%-4
-Change in payables and accrued expense
-473.99%-25.78K
625.10%12.93K
-65.41%11.61K
-19.21%64.21K
-1,957.71%-45.64K
90.63%-4.49K
-158.24%-2.46K
143.89%33.57K
164.10%79.47K
97.32%-2.22K
Cash from discontinued investing activities
Operating cash flow
-1,017.40%-662.03K
-51.41%-105.7K
-45.56%-342.24K
-546.87%-101.79K
-279.93%-111.39K
54.83%-59.25K
-18.54%-69.81K
51.12%-235.12K
88.02%-15.74K
69.45%-29.32K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
11,694.61%711.68K
0
93.32%-6.14K
-131.54%-6.14K
Net issuance payments of debt
----
----
--0
----
----
----
--0
93.32%-6.14K
-132.80%-6.14K
----
Net common stock issuance
----
----
--730.62K
----
----
----
----
--0
----
----
Net other financing activities
----
----
---18.95K
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
----
----
11,694.61%711.68K
----
----
----
--0
93.32%-6.14K
-131.54%-6.14K
----
Net cash flow
Beginning cash position
33.68%1.32M
34.85%1.43M
-18.54%1.06M
-24.24%819.77K
-16.22%931.17K
-19.74%990.41K
-18.54%1.06M
-30.57%1.3M
-23.44%1.08M
-28.34%1.11M
Current changes in cash
-1,017.40%-662.03K
-51.41%-105.7K
253.13%369.44K
2,888.18%609.89K
-279.93%-111.39K
51.69%-59.25K
-3.53%-69.81K
57.89%-241.26K
80.45%-21.87K
78.69%-29.32K
End cash Position
-28.91%661.94K
33.68%1.32M
34.85%1.43M
34.85%1.43M
-24.24%819.77K
-16.22%931.17K
-19.74%990.41K
-18.54%1.06M
-18.54%1.06M
-23.44%1.08M
Free cash from
-1,017.40%-662.03K
-51.41%-105.7K
-45.56%-342.24K
-546.87%-101.79K
-279.93%-111.39K
54.83%-59.25K
-18.54%-69.81K
51.12%-235.12K
88.02%-15.74K
69.45%-29.32K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Dec 31, 2025(Q1)Sep 30, 2025(FY)Jun 30, 2025(Q4)Jun 30, 2025(Q3)Mar 31, 2025(Q2)Dec 31, 2024(Q1)Sep 30, 2024(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -1,049.38%-680.97K-51.41%-105.7K-45.56%-342.24K-546.87%-101.79K-279.93%-111.39K54.83%-59.25K-18.54%-69.81K51.12%-235.12K88.02%-15.74K69.45%-29.32K
Net income from continuing operations -480.93%-339.32K-137.86%-171.91K-31.76%-447.79K-118.74%-239.7K-90.96%-77.41K47.68%-58.41K7.44%-72.27K80.92%-339.85K90.45%-109.58K63.34%-40.54K
Operating gains losses -----------------------------98.36%4.14K--------
Depreciation and amortization ----------0--0--0--0--0-69.18%20.37K104.37%797-97.15%797
Asset impairment expenditure ------------------------------0--------
Remuneration paid in stock ---30.51K345.99%60.49K451.65%97.54K265.15%83.97K--0--026.05%13.56K-78.80%17.68K-184.70%-50.85K--7.44K
Other non cashItems ---------44.28%16.5K--0-------------96.05%29.62K-93.03%48.39K--0
Change In working capital -37,029.71%-311.15K151.53%5.72K-125.78%-8.49K-40.97%53.93K-1,794.09%-50.48K98.38%-838-16.31%-11.1K-75.89%32.92K356.55%91.37K108.08%2.98K
-Change in receivables -2,722.75%-38.59K249.16%10.94K-362.80%-38.88K-210.44%-12.28K-42.37%-17.9K-105.38%-1.37K19.74%-7.34K-78.34%14.8K294.35%11.12K-241.31%-12.57K
-Change in inventory -1,735.25%-33.03K--0172.85%22.67K--0-24.84%13.36K104.45%2.02K13.12%7.29K-1,826.64%-31.11K-15.52%-9.92K582.64%17.78K
-Change in prepaid assets -7,225.00%-213.75K-111.29%-18.15K-124.79%-3.89K-81.24%2.01K-7,450.00%-302-81.30%3K22.43%-8.59K-89.04%15.67K152.78%10.7K-100.01%-4
-Change in payables and accrued expense -473.99%-25.78K625.10%12.93K-65.41%11.61K-19.21%64.21K-1,957.71%-45.64K90.63%-4.49K-158.24%-2.46K143.89%33.57K164.10%79.47K97.32%-2.22K
Cash from discontinued investing activities
Operating cash flow -1,017.40%-662.03K-51.41%-105.7K-45.56%-342.24K-546.87%-101.79K-279.93%-111.39K54.83%-59.25K-18.54%-69.81K51.12%-235.12K88.02%-15.74K69.45%-29.32K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 11,694.61%711.68K093.32%-6.14K-131.54%-6.14K
Net issuance payments of debt ----------0--------------093.32%-6.14K-132.80%-6.14K----
Net common stock issuance ----------730.62K------------------0--------
Net other financing activities -----------18.95K----------------------------
Cash from discontinued financing activities
Financing cash flow --------11,694.61%711.68K--------------093.32%-6.14K-131.54%-6.14K----
Net cash flow
Beginning cash position 33.68%1.32M34.85%1.43M-18.54%1.06M-24.24%819.77K-16.22%931.17K-19.74%990.41K-18.54%1.06M-30.57%1.3M-23.44%1.08M-28.34%1.11M
Current changes in cash -1,017.40%-662.03K-51.41%-105.7K253.13%369.44K2,888.18%609.89K-279.93%-111.39K51.69%-59.25K-3.53%-69.81K57.89%-241.26K80.45%-21.87K78.69%-29.32K
End cash Position -28.91%661.94K33.68%1.32M34.85%1.43M34.85%1.43M-24.24%819.77K-16.22%931.17K-19.74%990.41K-18.54%1.06M-18.54%1.06M-23.44%1.08M
Free cash from -1,017.40%-662.03K-51.41%-105.7K-45.56%-342.24K-546.87%-101.79K-279.93%-111.39K54.83%-59.25K-18.54%-69.81K51.12%-235.12K88.02%-15.74K69.45%-29.32K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More